ClinicalTrials.Veeva

Menu

Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection

U

University Hospital Essen

Status

Completed

Conditions

Cardiovascular Diseases
Cardiovascular Risk Factor
SARS

Treatments

Diagnostic Test: Assessment of cardiovascular diseases and cardiovascular risk factors

Study type

Observational

Funder types

Other

Identifiers

NCT04327479
20-9213-BO

Details and patient eligibility

About

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.

Enrollment

728 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with suspected SARS-CoV2/Covid-19 infection

Exclusion criteria

  • Unwillingness to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems